Philippe Marchand
Analista di Private Equity presso Investissement Québec
Profilo
Philippe Marchand is currently an Analyst at Investissement Québec since 2019.
Prior to this, he held positions as Principal at Edwards Lifesciences Corp., CryoCath Technologies, Inc., and Senior Engineer-Research & Development at ev3, Inc. He also worked as Manager-Research & Development at Sequent Medical, Inc. Marchand received his undergraduate and graduate degrees from McGill University.
Posizioni attive di Philippe Marchand
| Società | Posizione | Inizio |
|---|---|---|
Investissement Québec
 Investissement Québec Investment ManagersFinance Investissement Québec (Investissement Quebec) is a Private Equity/Venture Capital firm, a subsidiary of Province of Québec founded in 1998. The firm is headquartered in Montréal. | Analista di Private Equity | 07/01/2019 |
Precedenti posizioni note di Philippe Marchand
| Società | Posizione | Fine |
|---|---|---|
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Direttore Tecnico/Scientifico/R&S | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Corporate Officer/Principal | - |
Sequent Medical, Inc.
 Sequent Medical, Inc. Medical SpecialtiesHealth Technology Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Philippe Marchand
| McGill University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| Aziende private | 4 |
|---|---|
Sequent Medical, Inc.
Sequent Medical, Inc. Medical SpecialtiesHealth Technology Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA. | Health Technology |
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Investissement Québec
Investissement Québec Investment ManagersFinance Investissement Québec (Investissement Quebec) is a Private Equity/Venture Capital firm, a subsidiary of Province of Québec founded in 1998. The firm is headquartered in Montréal. | Finance |
- Borsa valori
- Insiders
- Philippe Marchand
